The Euro-CRAFT Registry

NCT ID: NCT05805462

Last Updated: 2026-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

671 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-22

Study Completion Date

2030-09-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Euro-CRAFT Registry is a prospective, multicentric, international registry of patients undergoing functional assessment of the coronary microcirculation using the continuous thermodilution technique. Angina and quality of life questionnaires (Seattle Angina Questionnaire 19 - SAQ19, ORBITA app) will be obtained at baseline, at 6 months, and 1-year follow-up. Clinical follow-up will be performed at 1 year (optionally until 5 years).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Microvascular Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years.
* Stable patients should have complaints of chest pain suspected of angina pectoris or other symptoms raising the suspicion of IHD and non-obstructive epicardial coronary arteries on invasive coronary angiography (ICA, diameter stenosis of less than 50%) with an FFR \>0.80.
* Any other clinical scenario (including in the context of ACS) prompting the physician to assess the function of the coronary microvasculature.

Exclusion Criteria

* Unable to provide consent
* Unstable hemodynamics
* Ongoing chest pain.
* Previous CABG
* Moderate to severe valvular heart disease
* Uncontrolled or recurrent ventricular tachycardia.
* Active liver disease or hepatic dysfunction, defined as AST or ALT \> 3 times the ULN.
* Comorbidity with life expectancy \<= 2 years.
* Severe renal dysfunction, defined as an eGFR \<30 mL/min/1.73 m2.
* Subject is currently participating in another investigational drug or device clinical study.
* Presence of other anatomic or comorbid conditions, or other medical, social or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hexacath, France

INDUSTRY

Sponsor Role collaborator

CoreAalst BV

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

OLV Ziekenhuis Aalst

Aalst, , Belgium

Site Status

Righospitalet

Copenhagen, , Denmark

Site Status

University of Mainz

Mainz, , Germany

Site Status

Catharina Hospital

Eindhoven, , Netherlands

Site Status

Radboud Hospital

Nijmegen, , Netherlands

Site Status

Maasstad Ziekenhuis

Rotterdam, , Netherlands

Site Status

University Clinical Center of Serbia, University of Belgrade

Belgrade, , Serbia

Site Status

University Hospital Puerta del Mar

Cadiz, , Spain

Site Status

Clinica La Princesa

Madrid, , Spain

Site Status

San Carlos Hospital

Madrid, , Spain

Site Status

University Hospital Lausanne

Lausanne, , Switzerland

Site Status

Royal United Hospital Bath NHS Foundation Trust

Bath, , United Kingdom

Site Status

Bristol Heart Institute

Bristol, , United Kingdom

Site Status

Basildon Hospital

Essex, , United Kingdom

Site Status

Golden Jubilee National Hospital

Glasgow, , United Kingdom

Site Status

Imperial College

London, , United Kingdom

Site Status

Royal Brompton Hospital

London, , United Kingdom

Site Status

St. Thomas Hospital, King's College

London, , United Kingdom

Site Status

Oxford University Hospitals

Oxford, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Denmark Germany Netherlands Serbia Spain Switzerland United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CRI-080

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prospective Registry on Intravascular Lithotripsy
NCT06577038 ENROLLING_BY_INVITATION
Multicentre Registry of CCTA, IVUS and OCT
NCT04066062 ACTIVE_NOT_RECRUITING
Chronic Total Occlusion Registry
NCT02352818 RECRUITING